Anti-Thrombin III Testing Market by End-user and Geography - Forecast and Analysis 2022-2026

Published: Jun 2022

Pages: 137

SKU: IRTNTR73611

Snapshot

The anti-thrombin III testing market share is expected to increase to USD 161.48 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.73%.

This anti-thrombin III testing market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers anti-thrombin III testing market segmentation by end-user (hospitals, laboratories, and academic and research institutes) and geography (North America, Europe, Asia, and Rest of World (ROW)). The anti-thrombin III testing market report also offers information on several market vendors, including Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Biron Health Group Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Invitae Corp., Merck KGaA, Meridian Bioscience Inc., Oy Medix Biochemica Ab, Randox Laboratories Ltd., Scripps Laboratories Inc., Sekisui Diagnostics LLC, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Transasia Bio Medicals Ltd., and Werfenlife SA among others.

What will the Anti-Thrombin III Testing Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Anti-Thrombin III Testing Market Size for the Forecast Period and Other Important Statistics

Anti-Thrombin III Testing Market: Key Drivers, Trends, and Challenges

The existence of tests related to anti-thrombin III is notably driving the anti-thrombin III testing market growth, although factors such as lack of clinically available protocols to treat anti-thrombin deficiency may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the anti-thrombin III testing industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Anti-Thrombin III Testing Market Driver

One of the key factors driving the global anti-thrombin III testing market growth is the existence of tests for patients with anti-thrombin deficiency. The testing comprises a range of related tests, which aid in the detection of blood clots, as given below:

Prothrombin time (PT) test - The PT test helps in measuring the time it takes for the liquid part of the blood (plasma) to form a clot.
Activated partial thromboplastin time (aPTT) test - Activated partial thromboplastin time is used to measure the intrinsic pathway involved in the process of blood clotting.
Thrombin time (TT) test - This test measures the time it takes for a clot to form in the plasma of a blood sample containing anticoagulant after an excess of thrombin has been added.

The presence of such tests, which aid in timely medical intervention and enable the correct treatment of patients, will boost the demand for anti-thrombin III testing products during the forecast period.

Key Anti-Thrombin III Testing Market Trend

The presence of various blood clotting disorders is one of the key anti-thrombin III testing market trends that is expected to impact the industry positively in the forecast period. Anti-thrombin presents many symptoms that are very similar to other disorders, such as protein S deficiency, antiphospholipid syndrome, and protein C deficiency.

Protein C deficiency ? It is characterized by the abnormal formation of blood clots and pulmonary emboli. Patients suffering from this deficiency have approximately 50% of the normal level of this factor in their blood.
Protein S deficiency ? It is characterized by the formation of recurrent blood clots and emboli.
Antiphospholipid syndrome ? It causes blood clots in the veins or arteries. Inflammation and thickening of the valves of the heart, migraine headaches, and skin rashes are some of the symptoms.

Key Anti-Thrombin III Testing Market Challenge

One of the key challenges to the global anti-thrombin III testing market growth is the lack of clinically available protocols to treat anti-thrombin deficiency. Intravenous anti-thrombin concentrates are prescribed during surgery or child delivery, which are used to prevent venous clots when blood thinners such as heparin are not advisable, as they can lead to an increased risk of bleeding. For heparin to work effectively, an adequate amount of anti-thrombin must be present in the blood. Pregnant women with anti-thrombin deficiency are at a particularly high risk of developing clots during pregnancy or after delivery. In addition, patients with anti-thrombin deficiency who undergo surgery are at increased risk unless appropriate preventive measures are taken. Thus, the lack of clinically available protocols to treat anti-thrombin deficiency may hamper the demand for anti-thrombin kits and reagents and limit the market growth in the coming years.

This anti-thrombin III testing market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global anti-thrombin III testing market as a part of the global life science tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the anti-thrombin III testing market during the forecast period.

Who are the Major Anti-Thrombin III Testing Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

This statistical study of the anti-thrombin III testing market encompasses successful business strategies deployed by the key vendors. The anti-thrombin III testing market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market.

Product Insights and News

Abbott Laboratories - The company offers anti-thrombin III testing products such as CP3000 lab auto system assembly kit.
Becton Dickinson and Co. - The company offers anti-thrombin III testing products such as BD vacutainer evacuated blood collection system.

To make the most of the opportunities and recover from post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The anti-thrombin III testing market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Anti-Thrombin III Testing Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the anti-thrombin III testing market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Anti-Thrombin III Testing Market?

For more insights on the market share of various regions Request for a FREE sample now!

38% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for anti-thrombin III testing in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).

The growing adoption of anti-thrombin III testing for blood disorders in hospitals and laboratories will facilitate the anti-thrombin III testing market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The cases of COVID-19 have increased significantly across North America. For instance, according to the Centers for Medicare and Medicaid Services (CMS), healthcare expenditure in the US was around USD 12,530 per person in 2021, an increase of 4.6% from the previous year. The growing prevalence of COVID-19 has increased the demand for a wide range of anti-thrombin III testing for the treatment of patients with COVID-19. Furthermore, governments' desire to provide the greatest health care fuels the demand for innovative treatments. This feature is projected to create a favorable environment for the regional anti-thrombin III testing market during the forecast period.

What are the Revenue-generating End-user Segments in the Anti-Thrombin III Testing Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The anti-thrombin III testing market share growth by the hospital segment will be significant during the forecast period. Hospitals make use of anti-thrombin III testing products like assay kits, reagents, and systems to carry out diagnostic tests. The sales of anti-thrombin III testing products in hospitals will increase due to the increase in patient admissions for surgeries and diagnoses.

This report provides an accurate prediction of the contribution of all the segments to the growth of the anti-thrombin III testing market size and actionable market insights on the post-COVID-19 impact on each segment.

Anti-Thrombin III Testing Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 7.73%
Market growth 2022-2026	$161.48 million
Market structure	Fragmented
YoY growth (%)	5.3
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 38%
Key consumer countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Biron Health Group Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Grifols SA, Invitae Corp., Merck KGaA, Meridian Bioscience Inc., Oy Medix Biochemica Ab, Randox Laboratories Ltd., Scripps Laboratories Inc., Sekisui Diagnostics LLC, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Transasia Bio Medicals Ltd., and Werfenlife SA
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Anti-Thrombin III Testing Market Report?

CAGR of the market during the forecast period 2022-2026
Detailed information on factors that will drive anti-thrombin III testing market growth during the next five years
Precise estimation of the anti-thrombin III testing market size and its contribution to the parent market
Accurate predictions on upcoming trends and changes in consumer behavior
The growth of the anti-thrombin III testing industry across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of anti-thrombin III testing market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 12: Market segments

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

5.1 Market segments
- Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
- Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)

5.2 Comparison by End-user
- Exhibit 26: Chart on Comparison by End-user
- Exhibit 27: Data Table on Comparison by End-user

5.3 Hospitals - Market size and forecast 2021-2026
- Exhibit 28: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)

5.4 Laboratories - Market size and forecast 2021-2026
- Exhibit 32: Chart on Laboratories - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Laboratories - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Laboratories - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Laboratories - Year-over-year growth 2021-2026 (%)

5.5 Academic and research institutes - Market size and forecast 2021-2026
- Exhibit 36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)

5.6 Market opportunity by End-user
- Exhibit 40: Market opportunity by End-user ($ million)

6 Customer Landscape

6.1 Customer landscape overview
- Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
- Exhibit 42: Chart on Market share by geography 2021-2026 (%)
- Exhibit 43: Data Table on Market share by geography 2021-2026 (%)

7.2 Geographic comparison
- Exhibit 44: Chart on Geographic comparison
- Exhibit 45: Data Table on Geographic comparison

7.3 North America - Market size and forecast 2021-2026
- Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)

7.4 Europe - Market size and forecast 2021-2026
- Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)

7.5 Asia - Market size and forecast 2021-2026
- Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)

7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

7.7 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)

7.8 Germany - Market size and forecast 2021-2026
- Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)

7.9 China - Market size and forecast 2021-2026
- Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)

7.10 UK - Market size and forecast 2021-2026
- Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)

7.11 Canada - Market size and forecast 2021-2026
- Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)

7.12 Market opportunity by geography
- Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges
- Exhibit 83: Impact of drivers and challenges in 2021 and 2026

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape
- Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

9.3 Landscape disruption
- Exhibit 85: Overview on factors of disruption

9.4 Industry risks
- Exhibit 86: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
- Exhibit 87: Vendors covered

10.2 Market positioning of vendors
- Exhibit 88: Matrix on vendor position and classification

10.3 Abbott Laboratories
- Exhibit 89: Abbott Laboratories - Overview
- Exhibit 90: Abbott Laboratories - Business segments
- Exhibit 91: Abbott Laboratories - Key news
- Exhibit 92: Abbott Laboratories - Key offerings
- Exhibit 93: Abbott Laboratories - Segment focus

10.4 Becton Dickinson and Co.
- Exhibit 94: Becton Dickinson and Co. - Overview
- Exhibit 95: Becton Dickinson and Co. - Business segments
- Exhibit 96: Becton Dickinson and Co. - Key news
- Exhibit 97: Becton Dickinson and Co. - Key offerings
- Exhibit 98: Becton Dickinson and Co. - Segment focus

10.5 Bio Rad Laboratories Inc.
- Exhibit 99: Bio Rad Laboratories Inc. - Overview
- Exhibit 100: Bio Rad Laboratories Inc. - Business segments
- Exhibit 101: Bio Rad Laboratories Inc. - Key news
- Exhibit 102: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 103: Bio Rad Laboratories Inc. - Segment focus

10.6 Danaher Corp.
- Exhibit 104: Danaher Corp. - Overview
- Exhibit 105: Danaher Corp. - Business segments
- Exhibit 106: Danaher Corp. - Key news
- Exhibit 107: Danaher Corp. - Key offerings
- Exhibit 108: Danaher Corp. - Segment focus

10.7 F. Hoffmann La Roche Ltd.
- Exhibit 109: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 110: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 111: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 112: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 113: F. Hoffmann La Roche Ltd. - Segment focus

10.8 Grifols SA
- Exhibit 114: Grifols SA - Overview
- Exhibit 115: Grifols SA - Business segments
- Exhibit 116: Grifols SA - Key offerings
- Exhibit 117: Grifols SA - Segment focus

10.9 Siemens AG
- Exhibit 118: Siemens AG - Overview
- Exhibit 119: Siemens AG - Business segments
- Exhibit 120: Siemens AG - Key news
- Exhibit 121: Siemens AG - Key offerings
- Exhibit 122: Siemens AG - Segment focus

10.10 Sysmex Corp.
- Exhibit 123: Sysmex Corp. - Overview
- Exhibit 124: Sysmex Corp. - Business segments
- Exhibit 125: Sysmex Corp. - Key offerings
- Exhibit 126: Sysmex Corp. - Segment focus

10.11 Thermo Fisher Scientific Inc.
- Exhibit 127: Thermo Fisher Scientific Inc. - Overview
- Exhibit 128: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 129: Thermo Fisher Scientific Inc. - Key news
- Exhibit 130: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 131: Thermo Fisher Scientific Inc. - Segment focus

10.12 Transasia Bio Medicals Ltd.
- Exhibit 132: Transasia Bio Medicals Ltd. - Overview
- Exhibit 133: Transasia Bio Medicals Ltd. - Product / Service
- Exhibit 134: Transasia Bio Medicals Ltd. - Key offerings

11 Appendix

11.1 Scope of the report

11.2 Inclusions and exclusions checklist
- Exhibit 135: Inclusions checklist
- Exhibit 136: Exclusions checklist

11.3 Currency conversion rates for US$
- Exhibit 137: Currency conversion rates for US$

11.4 Research methodology
- Exhibit 138: Research methodology
- Exhibit 139: Validation techniques employed for market sizing
- Exhibit 140: Information sources

11.5 List of abbreviations
- Exhibit 141: List of abbreviations

growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.

product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

anti-thrombin iii testing market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis